Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Personalized diet after stroke may save lives, large trial tests

NCT ID NCT07065929

Disease control Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 02, 2026 · Updated 3 times

Summary

This study tests whether giving stroke patients a personalized diet plan within two days can lower the risk of death within 30 days. About 3,084 adults with moderate to severe stroke will take part. Dietitians will track food intake and adjust nutrition, using supplements or tube feeding if needed, to prevent malnutrition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized nutritional management (dietary supplements and meal enrichment)
What this could lead to
If it works, this could show that tailored nutrition soon after a stroke lowers the chance of dying within a month.
What could go wrong
This is a pragmatic trial, not a blinded drug test, so results may be influenced by differences in hospital care. The benefit may be small or not apply to all stroke types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,084 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Patients ≥ 18 years of age * With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke * NIHSS score ≥ 5 * Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients * Stroke less than 2 days old * Anticipated length of hospital stay in a participating centre ≥ 5 days * Patient affiliated to or benefiting from a social security scheme * Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives or patients enrolled under the emergency protocol when no family members were present within 2 days of the stroke. Exclusion Criteria: * Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.). * In a palliative situation where life expectancy is \< 3 months * Patient taking part in another study with an impact on mortality or nutrition * Previous inclusion in the trial * Pregnant, breast-feeding or parturient woman * Patient unable to follow the protocol for any reason * Patient deprived of liberty by judicial or administrative decision * Patient under compulsory psychiatric care * Person under legal protection * Poor understanding of the French language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute hemorrhagic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Chartres

    RECRUITING

    Le Coudray, 28630, France

  • CH Cholet

    RECRUITING

    Cholet, 49300, France

  • CH La Rochelle

    RECRUITING

    La Rochelle, 17000, France

  • CH St Malo

    RECRUITING

    St-Malo, 35043, France

  • CH Versailles

    RECRUITING

    Chesnay, Yvelines, 78150, France

  • CHD La Roche sur Yon

    RECRUITING

    La Roche-sur-Yon, 85925, France

  • CHU Angers

    RECRUITING

    Angers, 49933, France

  • CHU Caen

    RECRUITING

    Caen, 14033, France

  • CHU Nantes

    NOT_YET_RECRUITING

    Saint-Herblain, 44800, France

  • CHU Rouen

    RECRUITING

    Rouen, 76000, France

  • CHU Toulouse

    RECRUITING

    Toulouse, 31059, France

  • CHU Tours

    RECRUITING

    Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.